Stock listing

ROVI Stock Price, News, Filings & Events — Laboratorios Farmaceuticos Rovi, S.a.

Selected listing: ROVI · VIE · EUR · AT

This page tracks Laboratorios Farmaceuticos Rovi, S.a.'s ROVI:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ROVI:VIE. ROVI:VIE is the stock-level entry point for investors researching Laboratorios Farmaceuticos Rovi, S.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Laboratorios Farmaceuticos Rovi, S.A. is a public company listed on the Spanish market under the ticker ROVI. The company has a market capitalization of approximately €3.34 billion. Rovi specializes in the pharmaceutical industry, focusing on the development and manufacturing of various healthcare products.

ROVI:VIEEURATUpdated September 19, 2026

Ticker: ROVI:VIE
Asset type: Stock
Market cap: $3.40B
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: VIE
Currency: EUR

Laboratorios Farmaceuticos Rovi, S.a. ROVI:VIE stock context

Latest news from Laboratorios Farmaceuticos Rovi, S.a.

Laboratorios Farmaceuticos Rovi S A : First half 2026 results press release

July 23, 2026

Laboratorios Farmaceuticos Rovi S A : ROVI and the Regional Government of Castilla-La Mancha promote a framework of collaboration to modernise healthcare services through technological innovation

July 8, 2026

Laboratorios Farmaceuticos Rovi S A : First three months of 2026 results press release

May 6, 2026

Laboratorios Farmaceuticos Rovi S A : 2025 results press release

February 25, 2026

Laboratorios Farmaceuticos Rovi S A : ROVI releases the press release in relation to the signing of the definitive collaboration agreement with Roche for the manufacture of a new medicine in development

November 18, 2025

All Laboratorios Farmaceuticos Rovi, S.a. news →

Laboratorios Farmaceuticos Rovi, S.a. earnings calls

Laboratorios Farmaceuticos Rovi, S.A. (0ILL) Q1 2026 Earnings Call

May 6, 2026 · Replay with transcript and chapters

Research Laboratorios Farmaceuticos Rovi, S.a.

Laboratorios Farmaceuticos Rovi, S.a. investor report

Review AI stock analysis and investor report context for ROVI:VIE.

Laboratorios Farmaceuticos Rovi, S.a. company profile

View the public company page for Laboratorios Farmaceuticos Rovi, S.a. on 6ix.

Laboratorios Farmaceuticos Rovi, S.a. news

Read company news and market updates connected to Laboratorios Farmaceuticos Rovi, S.a..

Laboratorios Farmaceuticos Rovi, S.a. investor events

Find investor webinars, events, and replay context for Laboratorios Farmaceuticos Rovi, S.a..